Investor

Synlico Inc. is focusing on changing our current way of thinking about biological system and developing design-based engineering process for drug development. We are focusing on oncology, while believing our technology goes way beyond cancer. 

If you are interested in more information about our company, please send your inquiry to investor@synlico.com.